Multi-Drug Resistant Reversal Agents:An Overview of Structure-Activity Relationship

سال انتشار: 1392
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 90

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

COSPC01_031

تاریخ نمایه سازی: 30 شهریور 1402

چکیده مقاله:

Multidrug resistance (MDR) against various anticancer drugs ofdifferent compound classes has maintained thecentral problem in anticancer drug therapies over the last decades. Multidrug efflux pumps of various types havebeen identified to be mainly causative agents in the multidrug affected process of MDR by transportinganticancerdrugs out of the cells.Therefore, effective intracellular drug levels are no longer reached.P-Glycoprotein,the plasma membrane protein responsible forthe multidrug resistance of some tumor cells, is an activetransporter ofa number of structurally unrelated hydrophobicdrugs.The inhibition of the efflux pump activity by drugs turned out as the most perspective approach to combat MDR.MDR reversing agents which are categorized into three classes are diverse andstructurally unrelated compounds.Knowing structure-activity relationships would help us to design more effective MDR reversing agents that areurgently needed for clinical use.In this study structure –activity relationships(SAR) of MDR reversing agents arediscussed and somesubstructural features related to MDR activity were identified. For example, the CH۲ –CH۲–N–CH۲–CH۲ group was found in most of the active compounds, and the activity was further enhanced by the presenceof (di)methoxylphenyl groups, whereas the presence of a stable quaternary ammonium salt, a carboxylic, a phenol,or an aniline group was found to be detrimental to activity.

نویسندگان

Sara. Ranjbar

Medicinal and Natural Products Chemistry Research Center, Shiraz, Iran Department of Medicinal Chemistry, School of Pharmacy,Shiraz University of Medical Sciences, Shiraz, Iran

Najmeh. Edraki

Department of Medicinal Chemistry, School of Pharmacy,Shiraz University of Medical Sciences, Shiraz, Iran

Mehdi. Khoshnevis zadeh

Medicinal and Natural Products Chemistry Research Center, Shiraz, Iran Department of Medicinal Chemistry, School of Pharmacy,Shiraz University of Medical Sciences, Shiraz, Iran

Omid.R. firuzi

Department of Medicinal Chemistry, School of Pharmacy,Shiraz University of Medical Sciences, Shiraz, Iran

Ramin. Miri

Medicinal and Natural Products Chemistry Research Center, Shiraz, Iran Department of Medicinal Chemistry, School of Pharmacy,Shiraz University of Medical Sciences, Shiraz, Iran

Ommolbanin Shahraki

Medicinal and Natural Products Chemistry Research Center, Shiraz, Iran Department of Medicinal Chemistry, School of Pharmacy,Shiraz University of Medical Sciences, Shiraz, Iran